1. Home
  2. MLSS vs NSRX Comparison

MLSS vs NSRX Comparison

Compare MLSS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.56

Market Cap

42.6M

Sector

Health Care

ML Signal

HOLD

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.31

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
NSRX
Founded
1989
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
38.9M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
MLSS
NSRX
Price
$0.56
$3.31
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.00
$19.67
AVG Volume (30 Days)
133.3K
10.8K
Earning Date
05-14-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,973,982.00
N/A
Revenue This Year
$12.64
N/A
Revenue Next Year
$8.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.99
N/A
52 Week Low
$0.22
$1.98
52 Week High
$0.68
$9.99

Technical Indicators

Market Signals
Indicator
MLSS
NSRX
Relative Strength Index (RSI) 73.26 52.47
Support Level $0.25 $2.83
Resistance Level N/A $3.60
Average True Range (ATR) 0.04 0.27
MACD 0.01 0.01
Stochastic Oscillator 86.19 50.00

Price Performance

Historical Comparison
MLSS
NSRX

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: